Global Osteoarthritis Therapeutics Market Size & Outlook

The osteoarthritis therapeutics industry worldwide is expected to reach a projected revenue of US$ 13,571.1 million by 2030. A compound annual growth rate of 6.9% is expected of the worldwide osteoarthritis therapeutics industry from 2025 to 2030.
Revenue, 2024 (US$M)
$9,139.2
Forecast, 2030 (US$M)
$13,571.1
CAGR, 2025 - 2030
6.9%
Report Coverage
Worldwide

Global osteoarthritis therapeutics market, 2018-2030 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Global osteoarthritis therapeutics market highlights

  • The global osteoarthritis therapeutics market generated a revenue of USD 8,589.3 million in 2023 and is expected to reach USD 13,571.1 million by 2030.
  • The market is expected to grow at a CAGR (2024 - 2030) of 6.8% by 2030.
  • In terms of segment, viscosupplementation agents accounted for a revenue of USD 3,146.1 million in 2023.
  • Viscosupplementation Agents is the most lucrative drug type segment registering the fastest growth during the forecast period.
  • In terms of region, North America was the largest revenue generating market in 2023.
  • Country-wise, U.S. is expected to register the highest CAGR from 2024 to 2030.

Global data book summary

Market revenue in 2023USD 8,589.3 million
Market revenue in 2030USD 13,571.1 million
Growth rate6.8% (CAGR from 2023 to 2030)
Largest segmentViscosupplementation agents
Fastest growing segmentViscosupplementation Agents
Historical data covered2018 - 2022
Base year for estimation2023
Forecast period covered2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationViscosupplementation Agents, Nonsteroidal Anti-inflammatory Drugs, Analgesics, Corticosteroids, Others Drug Type

Other key industry trends

  • In terms of revenue, the North America accounted for 37.7% of the global osteoarthritis therapeutics market in 2023.
  • By country, the U.S. is projected to lead the global market in terms of revenue in 2030.
  • By country, U.S. is the fastest growing regional market and is projected to reach USD 4,101.9 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Osteoarthritis Therapeutics Market Scope

Osteoarthritis therapeutics market segmentation & scope
Viscosupplementation Agents
Acetaminophen
Duloxetine
Corticosteroids
Ketoprofen
Other NSAIDs
Naproxen
Aspirin
Ibuprofen
Meloxicam
Diclofenac
Celecoxib
Piroxicam
Others Drug Type
Hand Osteoarthritis
Knee Osteoarthritis
Others Anatomy
Hip Osteoarthritis
Topical Route
Platelet-rich Plasma (PRP) Injections
Hyaluronic Acid Injections
Corticosteroid Injections
Placental Tissue Matrix (PTM) Injections
Acetylsalicylic Acid (ASA) Injections
Other Parenteral Routes
Oral Route
Prescription Drugs
Over-the-Counter Drugs
Retail Pharmacies
Hospital Pharmacies
Other End-users

Osteoarthritis Therapeutics Market Companies

Name Profile # Employees HQ Website

Global osteoarthritis therapeutics market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to osteoarthritis therapeutics market will help companies and investors design strategic landscapes.


Viscosupplementation agents was the largest segment with a revenue share of 36.63% in 2024. Horizon Databook has segmented the Global osteoarthritis therapeutics market based on viscosupplementation agents, nonsteroidal anti-inflammatory drugs, analgesics, corticosteroids, others drug type covering the revenue growth of each sub-segment from 2018 to 2030.


  • Global Osteoarthritis Therapeutics Drug Type Outlook (Revenue, USD Million, 2018-2030)
    • Viscosupplementation Agents
    • Analgesics
      • Acetaminophen
      • Duloxetine
    • Corticosteroids
    • Nonsteroidal Anti-inflammatory Drugs
      • Ketoprofen
      • Other NSAIDs
      • Naproxen
      • Aspirin
      • Ibuprofen
      • Meloxicam
      • Diclofenac
      • Celecoxib
      • Piroxicam
    • Others Drug Type
  • Global Osteoarthritis Therapeutics Anatomy Outlook (Revenue, USD Million, 2018-2030)
    • Hand Osteoarthritis
    • Knee Osteoarthritis
    • Others Anatomy
    • Hip Osteoarthritis
  • Global Osteoarthritis Therapeutics Route of Administration Outlook (Revenue, USD Million, 2018-2030)
    • Topical Route
    • Parenteral Route
      • Platelet-rich Plasma (PRP) Injections
      • Hyaluronic Acid Injections
      • Corticosteroid Injections
      • Placental Tissue Matrix (PTM) Injections
      • Acetylsalicylic Acid (ASA) Injections
      • Other Parenteral Routes
    • Oral Route
  • Global Osteoarthritis Therapeutics Sales Channel Outlook (Revenue, USD Million, 2018-2030)
    • Prescription Drugs
    • Over-the-Counter Drugs
  • Global Osteoarthritis Therapeutics End Use Outlook (Revenue, USD Million, 2018-2030)
    • Retail Pharmacies
    • Hospital Pharmacies
    • Other End-users

Reasons to subscribe to Global osteoarthritis therapeutics market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Global osteoarthritis therapeutics market databook

  • Our clientele includes a mix of osteoarthritis therapeutics market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of global-level data and insights on the Global osteoarthritis therapeutics market , including forecasts for subscribers. This global databook contains high-level insights into Global osteoarthritis therapeutics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Global osteoarthritis therapeutics market size, by regions, 2018-2030 (US$M)

Top 10 countries: Osteoarthritis therapeutics market size, 2023 (US$M)

Global osteoarthritis therapeutics market share, by drug type, 2023 & 2030 (%, US$M)

Osteoarthritis therapeutics market: Opportunity assessment by country

Global osteoarthritis therapeutics market, by region, 2024 (US$M)

Global osteoarthritis therapeutics market size, by regions, 2018-2030 (US$M)

Related regional statistics

No records

No related regions found.

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more